MikroScore
Marketing claims, evidence checked

Claims Check

"Glycine is non-essential — so it's unimportant"

✗ Falsch Non-essential means only that the body can synthesise glycine — not that endogenous production covers demand under real-world conditions.

Claim context

Evidence context

Ingredient

Glycin →

The claim

“If an amino acid is non-essential, we don’t need to consume it separately.”

Glycine is often dismissed along these lines — particularly in discussions around collagen or glutathione supplements.

What the evidence actually shows

The terminology problem

“Non-essential” is a classification term meaning that the body can, in principle, synthesise the amino acid. It says nothing about whether endogenous production is sufficient for actual physiological needs across all conditions.

Glycine is the simplest amino acid and one of the most abundant in the human body — a major component of collagen, a precursor to glutathione and haem, and a co-substrate in numerous biosynthetic reactions. The question is not whether it exists in the body, but whether the body produces enough.

What the research shows

  • Collagen synthesis: Studies on collagen production in connective tissue, skin, and bone indicate that glycine demand may routinely exceed endogenous production. Razak et al. (2017) estimated that the body can synthesise approximately 3 g of glycine per day, while requirements for full collagen synthesis may be substantially higher.
  • Glutathione: Glycine is one of three precursors for glutathione, the primary intracellular antioxidant. Limitation of glycine availability may constrain glutathione synthesis — a finding with implications for oxidative stress contexts.
  • Human trials: Several small RCTs report improvements in sleep quality, insulin sensitivity, and inflammatory markers with glycine supplementation (typically 3–5 g/day). These are preliminary findings but consistent with the concept of conditional insufficiency.

Researchers have proposed the concept of glycine being “conditionally essential” — meaning its endogenous production is adequate under some conditions but not others (high protein turnover, ageing, low dietary collagen intake).

EFSA and BfR status

  • EFSA: No health claims approved for glycine. This reflects the evidentiary standards for regulatory approval — not a scientific verdict that glycine has no physiological function.
  • BfR: No specific warnings or restrictions. Glycine is considered safe.

Verdict

This claim is false. Glycine is structurally and metabolically significant. Its non-essential classification does not negate the demand evidenced by both nutritional data and human trials. Dismissing it as unimportant because it can be synthesised conflates regulatory terminology with physiological reality.

Editorial notice: This page provides an editorial assessment of a widely circulated claim. It does not constitute an approved health claim under Regulation (EC) No 1924/2006 and is not a substitute for medical advice. Statements about studies, biomarkers, or mechanisms are to be understood as evidence appraisal — not as recommendations to treat, alleviate, or prevent any disease.
Legal context: Even where individual studies show positive effects, this does not automatically permit health-related advertising claims. What is relevant for foods and food supplements are the health claims approved in the EU and their conditions of use.